Relvar Ellipta: new once-daily steroid/LABA inhaler

    loading  Checking for direct PDF access through Ovid

Abstract

Relvar Ellipta is a new inhaled steroid/long-acting beta-agonist combination taken once daily. In our New products review, Steve Chaplin presents the data relating to its efficacy and adverse events, and Professor Neil Thomson discusses its place in therapy.

Related Topics

    loading  Loading Related Articles